Skip to main content
. 2014 Sep 16;1:707–717. doi: 10.1016/j.toxrep.2014.09.001

Fig. 4.

Fig. 4

(A) eNOS mRNA expression in the liver at various time points after treatment with DMN. Values are mean ± SEM, n = 3 (*p < 0.05). (B) Immunofluorescence staining for glial fibrillary acidic protein (GFAP) as a marker for stellate cells in liver sections from mice at various time points after a single intra-peritoneal dose of 10 mg/kg body weight DMN.